Functional studies in glioma cells and GBM neurospheres have shown that MCT4 increases tumor cell proliferation and survival, whereas MCT4 knockdown or pharmacological inhibition leads to apoptosis and necrosis [43,60]. The gene discussed is SLC16A3; the disease is glioma.